Search

everythinglearnresearchcommunity

for

Search:↓

Thorough patient interviews are crucial to identify self-inflicted hair loss.

Activating c-Myc in skin causes rapid cell growth and changes, but these effects are reversible.

A manufacturing error in a dietary supplement caused severe selenium poisoning, affecting many people and highlighting the need for stricter quality control.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Reactive oxygen species (ROS) help control plant growth and development.

Adult female acne requires personalized treatment and maintenance to prevent relapse.

Cannabinoids may help treat various skin conditions.

Shift work disrupts the body's natural clock, leading to health problems.

Mesenchymal stem cell therapy shows promise for liver disease but faces challenges in standardization and approval.

RpoS helps Borrelia burgdorferi survive in hosts and adapt to different environments.

Breast implants are generally safe, but textured implants may rarely cause lymphoma.

Personalized acne treatments and new therapies show promise for better results.

TREM2 macrophages and unsaturated lipids contribute to acne inflammation.

Oral isotretinoin may slightly improve acne but increases the risk of side effects like dry lips and skin; more research is needed to understand its full risks and benefits.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

IL-3 worsens lupus nephritis and blocking it improves kidney health.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

P144® improves hypertrophic scars by reducing size and thickness and increasing elasticity.

Medications for BPH can have significant side effects, so understanding these risks is important for treatment decisions.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

The guideline provides recommendations for managing alopecia areata effectively.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Dutasteride reduces DHT more than finasteride, but both drugs improve BPH symptoms similarly.